Synopsis
Synopsis
0
VMF
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol Hcl
2. Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, Hydrochloride
3. Dobupal
4. Efexor
5. Effexor
6. Hydrochloride, Venlafaxine
7. Sila Venlafaxine
8. Sila-venlafaxine
9. Trevilor
10. Vandral
11. Venlafaxine
12. Wy 45,030
13. Wy 45030
14. Wy-45,030
15. Wy-45030
16. Wy45,030
17. Wy45030
1. 99300-78-4
2. Venlafaxine Hcl
3. Effexor
4. Efexor
5. Effexor Xr
6. Dobupal
7. Vandral
8. Venlafaxinehydrochloride
9. Wy-45030
10. Venlafaxine (hydrochloride)
11. Wy 45030
12. Wy-45,030
13. Wy 45030 Hydrochloride
14. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol Hydrochloride
15. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol Hydrochloride
16. Nsc-745751
17. 7d7rx5a8mo
18. Venlafaxine (as Hydrochloride)
19. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol Hydrochloride
20. Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, Hydrochloride
21. 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol Hydrochloride
22. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride
23. Chebi:9944
24. Venlafaxine Hydrochloride [usan]
25. Venlafaxine Hydorchloride
26. Unii-7d7rx5a8mo
27. C17h27no2.hcl
28. Venlift
29. Vexor
30. D,l-venlafaxine, Hydrochloride
31. Venlafaxine Ea
32. Venlafaxine Xr
33. Effexor Lp
34. Effexor Xl
35. Efexor Xl
36. Venlafaxine, Hcl
37. Effexor (tn)
38. Venlafaxine Hydrochloride [usan:usp]
39. Venlafaxine Hydro Chloride
40. Dsstox_cid_27397
41. Dsstox_rid_82318
42. Dsstox_gsid_47397
43. Schembl41936
44. Mls001401454
45. Chembl1201066
46. Dtxsid8047397
47. Hy-b0196a
48. Bvf-012
49. Amy32694
50. Bcp21401
51. Dl-venlafaxine Hydrochloride- Bio-x
52. Tox21_302508
53. Tox21_500449
54. Nsc745751
55. S1441
56. Venlafaxine Hydrochloride (jan/usp)
57. Venlafaxine Hydrochloride [mi]
58. Akos000280874
59. Akos016340594
60. Ac-1696
61. Ccg-100979
62. Ccg-213270
63. H13v695
64. Ks-5049
65. Lp00449
66. Nc00229
67. Nsc 745751
68. Pw-4112
69. Venlafaxine Hydrochloride [jan]
70. Venlafaxine Hydrochloride [hsdb]
71. Ncgc00256703-01
72. Ncgc00261134-01
73. Venlafaxine Hydrochloride [mart.]
74. Venlafaxine Hydrochloride [vandf]
75. Bv164514
76. Smr000469154
77. Venlafaxine Hydrochloride [usp-rs]
78. Venlafaxine Hydrochloride [who-dd]
79. Cas-99300-78-4
80. Ft-0642395
81. Sw197609-3
82. V0110
83. Pf-00345408
84. D00821
85. Venlafaxine Hydrochloride [ep Impurity]
86. Venlafaxine Hydrochloride [ep Monograph]
87. Venlafaxine Hydrochloride [orange Book]
88. Venlafaxine Hydrochloride [usp Monograph]
89. A845995
90. Venlafaxine Hydrochloride, >=98% (hplc), Powder
91. Venlafaxine Hydrochloride 100 Microg/ml In Methanol
92. Q27108525
93. Venlafaxine Hydrochloride 100 Microg/ml In Acetonitrile
94. 1-[2-dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -hcl
95. Venlafaxine Hydrochloride 1.0 Mg/ml In Methanol (as Free Base)
96. 1-[2-(dimethylamino)-1-(4-methoxyph Enyl)ethyl]cyclohexanol Hydrochloride
97. 1-[2-dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol Hydrochloride
98. Venlafaxine Hydrochloride, European Pharmacopoeia (ep) Reference Standard
99. (+/-)-1-(.alpha.-((dimethylamino)methyl)-p-methoxybenzyl)cyclohexanol Hydrochloride
100. (rs)-1-(2-dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol Hydrochloride
101. 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-1-cyclohexanol Hydrochloride
102. Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, Hydrochloride (1:1
103. Venlafaxine For System Suitability, European Pharmacopoeia (ep) Reference Standard
104. Venlafaxine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
105. Venlafaxine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
106. Venlafaxine Hydrochloride Solution, 1.0 Mg/ml In Methanol (as Free Base), Ampule Of 1 Ml, Certified Reference Material
Molecular Weight | 313.9 g/mol |
---|---|
Molecular Formula | C17H28ClNO2 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 3 |
Rotatable Bond Count | 5 |
Exact Mass | 313.1808568 g/mol |
Monoisotopic Mass | 313.1808568 g/mol |
Topological Polar Surface Area | 32.7 Ų |
Heavy Atom Count | 21 |
Formal Charge | 0 |
Complexity | 279 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Effexor xr |
Drug Label | Effexor XR is an extended-release capsule for oral administration that contains venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or ()-1... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 150mg base; eq 37.5mg base; eq 75mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
2 of 4 | |
---|---|
Drug Name | Venlafaxine hydrochloride |
PubMed Health | Venlafaxine (By mouth) |
Drug Classes | Antidepressant |
Drug Label | Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (c... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 37.5mg; eq 100mg base; eq 225mg base; eq 50mg base; 150mg; eq 150mg base; eq 75mg base; 75mg; eq 25mg base; eq 37.5mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Anchen Pharms; Teva; Alembic Pharms; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Osmotica Pharm; Sun Pharma Global; Vintage; Valeant Bermuda; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan; Impax Labs; Heritage Ph |
3 of 4 | |
---|---|
Drug Name | Effexor xr |
Drug Label | Effexor XR is an extended-release capsule for oral administration that contains venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or ()-1... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Capsule, extended release |
Route | Oral |
Strength | eq 150mg base; eq 37.5mg base; eq 75mg base |
Market Status | Prescription |
Company | Wyeth Pharms |
4 of 4 | |
---|---|
Drug Name | Venlafaxine hydrochloride |
PubMed Health | Venlafaxine (By mouth) |
Drug Classes | Antidepressant |
Drug Label | Venlafaxine hydrochloride extended-release capsules for oral administration contain venlafaxine hydrochloride, a structurally novel antidepressant. It is designated (R/S)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl] cyclohexanol hydrochloride or (c... |
Active Ingredient | Venlafaxine hydrochloride |
Dosage Form | Tablet, extended release; Tablet; Capsule, extended release |
Route | oral; Oral |
Strength | 37.5mg; eq 100mg base; eq 225mg base; eq 50mg base; 150mg; eq 150mg base; eq 75mg base; 75mg; eq 25mg base; eq 37.5mg base |
Market Status | Tentative Approval; Prescription |
Company | Amneal Pharms; Wockhardt; Anchen Pharms; Teva; Alembic Pharms; Aurobindo Pharma; Sun Pharm Inds; Torrent Pharms; Osmotica Pharm; Sun Pharma Global; Vintage; Valeant Bermuda; Zydus Pharms Usa; Dr Reddys Labs; Orchid Hlthcare; Mylan; Impax Labs; Heritage Ph |
Antidepressive Agents, Second-Generation
A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. (See all compounds classified as Antidepressive Agents, Second-Generation.)
Serotonin and Noradrenaline Reuptake Inhibitors
Drugs that selectively block or suppress the plasma membrane transport of SEROTONIN and NORADRENALINE into axon terminals and are used as ANTIDEPRESSIVE AGENTS. (See all compounds classified as Serotonin and Noradrenaline Reuptake Inhibitors.)
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
Certificate Number : R1-CEP 2016-074 - Rev 01
Status : Valid
Issue Date : 2022-12-16
Type : Chemical
Substance Number : 2119
Venlafaxine Hydrochloride, Standard And Milled
Certificate Number : R1-CEP 2006-182 - Rev 04
Status : Valid
Issue Date : 2020-02-04
Type : Chemical
Substance Number : 2119
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Venlafaxine Hydrochloride, Polymorph B, Micronis...
Certificate Number : R1-CEP 2009-082 - Rev 02
Status : Valid
Issue Date : 2022-11-04
Type : Chemical
Substance Number : 2119
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
Certificate Number : R1-CEP 2006-183 - Rev 03
Status : Valid
Issue Date : 2022-10-14
Type : Chemical
Substance Number : 2119
Certificate Number : R1-CEP 2007-170 - Rev 01
Status : Valid
Issue Date : 2014-06-20
Type : Chemical
Substance Number : 2119
Venlafaxine Hydrochloride, Form B
Certificate Number : R1-CEP 2007-040 - Rev 00
Status : Valid
Issue Date : 2014-07-23
Type : Chemical
Substance Number : 2119
Certificate Number : R1-CEP 2006-277 - Rev 00
Status : Valid
Issue Date : 2012-11-23
Type : Chemical
Substance Number : 2119
Certificate Number : R0-CEP 2007-323 - Rev 02
Status : Withdrawn by Holder
Issue Date : 2009-10-19
Type : Chemical
Substance Number : 2119
Certificate Number : R1-CEP 2006-302 - Rev 01
Status : Valid
Issue Date : 2014-11-14
Type : Chemical
Substance Number : 2119
Certificate Number : R1-CEP 2006-283 - Rev 00
Status : Valid
Issue Date : 2014-03-21
Type : Chemical
Substance Number : 2119
NDC Package Code : 68069-0002
Start Marketing Date : 2009-10-28
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-2610
Start Marketing Date : 1998-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
NDC Package Code : 15308-1506
Start Marketing Date : 2012-12-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 72761-018
Start Marketing Date : 2019-03-22
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65691-0036
Start Marketing Date : 2005-09-16
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65977-0128
Start Marketing Date : 1997-10-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 69766-114
Start Marketing Date : 2024-03-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 17205-567
Start Marketing Date : 2024-04-18
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 52286-0006
Start Marketing Date : 2009-11-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62512-0055
Start Marketing Date : 1997-10-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
About the Company : LGM Pharma is a global leader in sourcing hard-to-find APIs and intermediates for the pharmaceutical and biotech industries. LGM is also a full service CDMO providing formulation, ...
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
About the Company : Cohance Lifesciences is a leading CDMO and API platform, offering products and services across all phases of a molecule’s lifecycle from development to commercialzation. With our...
Gonane has API manufacturing expertise in new-age Corticosteroids, Hormones and other pharma raw materials.
About the Company : Gonane Pharma, is a contract pharmaceutical company located in Gujarat, India, specializing in the manufacturing and marketing of Corticosteroids, Hormones, Antivirals, and Oncolog...
About the Company : Since its founding in 1962, MOEHS has produced Active Pharmaceutical Ingredients (APIs) for the international pharmaceutical industry. Thanks to a business history of more than 50 ...
Aarti Pharmalabs is a partner of choice for APIs & Intermediates and the largest Indian manufacturer of Xanthine Derivatives.
About the Company : Aarti Pharmalab, earlier the pharma division of Aarti Industries, is a leading Indian manufacturer of APIs. It has dedicated facilities to manufacture HPAPIs, corticosteroids, cyto...
About the Company : HRV Global is a leading global manufacturer, seller & exporter of a wide range of APIs, advanced intermediates, pellets, food grade chemicals, food additives & food ingredients. It...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Zeon Pharma Industries India Pvt ltd is an ISO & GMP certified manufacturer of Bulk drugs & Intermediate and also supplies our associate manufacturing plant API / Semi finish form...
TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.
About the Company : Founded in 1935, TAPI Technology & API Services has a long-standing tradition of advancing health through innovation and dedication. Today, we proudly build upon this legacy, drivi...
About the Company : Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutica...
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 25MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 37.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 50MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : Tablet
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : SR Capsule
Dosage Strength : 37.5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : SR Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info : Registered in EU
Registration Country : Germany
Brand Name :
Dosage Form : SR Capsule
Dosage Strength : 150MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Registered in EU
Registration Country : Germany
Regulatory Info :
Registration Country : Sweden
Brand Name : Efexor
Dosage Form : TABLETT
Dosage Strength : 75 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Efexor Depot
Dosage Form : DEPOTKAPSEL, HÅRD
Dosage Strength : 75 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Venlafaxin STADA
Dosage Form : DEPOTKAPSEL, HÅRD
Dosage Strength : 37,5 MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
73
PharmaCompass offers a list of Venlafaxine Hydrochloride API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Venlafaxine Hydrochloride manufacturer or Venlafaxine Hydrochloride supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Venlafaxine Hydrochloride manufacturer or Venlafaxine Hydrochloride supplier.
PharmaCompass also assists you with knowing the Venlafaxine Hydrochloride API Price utilized in the formulation of products. Venlafaxine Hydrochloride API Price is not always fixed or binding as the Venlafaxine Hydrochloride Price is obtained through a variety of data sources. The Venlafaxine Hydrochloride Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Venlafaxine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Venlafaxine Hydrochloride, including repackagers and relabelers. The FDA regulates Venlafaxine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Venlafaxine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Venlafaxine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Venlafaxine Hydrochloride supplier is an individual or a company that provides Venlafaxine Hydrochloride active pharmaceutical ingredient (API) or Venlafaxine Hydrochloride finished formulations upon request. The Venlafaxine Hydrochloride suppliers may include Venlafaxine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Venlafaxine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Venlafaxine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Venlafaxine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Venlafaxine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Venlafaxine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Venlafaxine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Venlafaxine Hydrochloride USDMF includes data on Venlafaxine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Venlafaxine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Venlafaxine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Venlafaxine Hydrochloride Drug Master File in Japan (Venlafaxine Hydrochloride JDMF) empowers Venlafaxine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Venlafaxine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Venlafaxine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Venlafaxine Hydrochloride suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Venlafaxine Hydrochloride Drug Master File in Korea (Venlafaxine Hydrochloride KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Venlafaxine Hydrochloride. The MFDS reviews the Venlafaxine Hydrochloride KDMF as part of the drug registration process and uses the information provided in the Venlafaxine Hydrochloride KDMF to evaluate the safety and efficacy of the drug.
After submitting a Venlafaxine Hydrochloride KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Venlafaxine Hydrochloride API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Venlafaxine Hydrochloride suppliers with KDMF on PharmaCompass.
A Venlafaxine Hydrochloride CEP of the European Pharmacopoeia monograph is often referred to as a Venlafaxine Hydrochloride Certificate of Suitability (COS). The purpose of a Venlafaxine Hydrochloride CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Venlafaxine Hydrochloride EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Venlafaxine Hydrochloride to their clients by showing that a Venlafaxine Hydrochloride CEP has been issued for it. The manufacturer submits a Venlafaxine Hydrochloride CEP (COS) as part of the market authorization procedure, and it takes on the role of a Venlafaxine Hydrochloride CEP holder for the record. Additionally, the data presented in the Venlafaxine Hydrochloride CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Venlafaxine Hydrochloride DMF.
A Venlafaxine Hydrochloride CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Venlafaxine Hydrochloride CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Venlafaxine Hydrochloride suppliers with CEP (COS) on PharmaCompass.
A Venlafaxine Hydrochloride written confirmation (Venlafaxine Hydrochloride WC) is an official document issued by a regulatory agency to a Venlafaxine Hydrochloride manufacturer, verifying that the manufacturing facility of a Venlafaxine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Venlafaxine Hydrochloride APIs or Venlafaxine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Venlafaxine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Venlafaxine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Venlafaxine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Venlafaxine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Venlafaxine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Venlafaxine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Venlafaxine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Venlafaxine Hydrochloride suppliers with NDC on PharmaCompass.
Venlafaxine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Venlafaxine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Venlafaxine Hydrochloride GMP manufacturer or Venlafaxine Hydrochloride GMP API supplier for your needs.
A Venlafaxine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Venlafaxine Hydrochloride's compliance with Venlafaxine Hydrochloride specifications and serves as a tool for batch-level quality control.
Venlafaxine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Venlafaxine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Venlafaxine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Venlafaxine Hydrochloride EP), Venlafaxine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Venlafaxine Hydrochloride USP).